HP
38
-2
EQT
59
2
IBM
54
4
URBN
38
-4
ILMN
32
-3
F
43
-8
HRL
39
15
AZO
46
-3
KMX
58
3
ABT
57
-5
BA
52
2
DHI
48
3
JPM
63
-4
EXC
54
-2
SRE
63
-3
RRC
63
3
GRMN
62
-3
MUR
43
3
IVZ
46
3
HUM
48
6
HP
38
-2
EQT
59
2
IBM
54
4
URBN
38
-4
ILMN
32
-3
F
43
-8
HRL
39
15
AZO
46
-3
KMX
58
3
ABT
57
-5
BA
52
2
DHI
48
3
JPM
63
-4
EXC
54
-2
SRE
63
-3
RRC
63
3
GRMN
62
-3
MUR
43
3
IVZ
46
3
HUM
48
6
Financhill
Back

Amicus Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
25

FOLD
Amicus Therapeutics

Last Price:
9.49
Seasonality Move:
7.75%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
246.88
Seasonality Move:
10.85%
Sell
25
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $9.59. The Score for FOLD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $248.79. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $9.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $248.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 29.32 Sell
Chaikin Money Flow: 783674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.22 - 11.78) Sell
Bollinger Bands (100): (10.18 - 11.54) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.64 Sell
Relative Strength Index (14 RSI): 39.68 Sell
Chaikin Money Flow: 997085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (254.01 - 292.55) Sell
Bollinger Bands (100): (248.69 - 281.73) Sell

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.01 Sell
20-day SMA: 10.86 Sell
50-day SMA: 10.88 Sell
200-day SMA: 11.01 Sell
8-day EMA: 10 Sell
20-day EMA: 10.52 Sell
50-day EMA: 10.8 Sell
200-day EMA: 11.03 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 252.75 Sell
20-day SMA: 267.61 Sell
50-day SMA: 273.13 Sell
200-day SMA: 210.87 Buy
8-day EMA: 250.09 Sell
20-day EMA: 262.36 Sell
50-day EMA: 266.92 Sell
200-day EMA: 230.73 Buy

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):